Article in Journal of the American Geriatrics Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03984396 (Optimal Medication Management in Alzheimer's Disease and Dementia), which is not on this map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Ariel R GreenDepartment of Medicine, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-4127-4617
Linda A WeffaldDepartment of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, Colorado, USA.
John D PowersInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
Melanie L DraceInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
Jonathan D NortonDepartment of Medicine, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cynthia M BoydDepartment of Medicine, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Elizabeth A BaylissInstitute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.
Funding
eAlign: A Patient Portal-based Intervention to Align Medications with What Matters MostR01AG077011 · NIA · JOHNS HOPKINS UNIVERSITY · PI Ariel Green, CHRISTINE D JONES · 2022 to 2026
$3.9M
Optimal Medication Management in Alzheimer's Disease and DementiaR33AG057289 · NIA · KAISER FOUNDATION RESEARCH INSTITUTE · PI BAYLISS, ELIZABETH A, BOYD, CYNTHIA MELINDA · 2019 to 2021
$2.2M
Patient-Centered Care for Older Adults with Multiple Chronic Conditions: Research and Mentoring ProgramK24AG056578 · NIA · JOHNS HOPKINS UNIVERSITY · PI BOYD, CYNTHIA MELINDA · 2017 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Assessing medication appropriateness as a deprescribing outcome. · full record | OpenQuestion